Pd(II)-catalyzed enantioselective C—H arylation of free carboxylic acids

US11021427B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11021427-B2
Application numberUS-201915733763-A
CountryUS
Kind codeB2
Filing dateApr 17, 2019
Priority dateApr 19, 2018
Publication dateJun 1, 2021
Grant dateJun 1, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention includes procedures for stereoselective β-acylation of carboxylic acids having a β-carbon atom. For example, stereoselective acylation procedures include the following reactions: (I)

First claim

Opening claim text (preview).

What is claimed is: 1. A method of stereoselective arylation of a β-carbon atom of a cyclopropanecarboxylic acid having a β-hydrogen atom, the cyclopropropanecarboxylic acid having either an α-substituent or having no α-substituent, comprising contacting the cyclopropanecarboxylic acid and an aryl iodide in the presence of a catalytic quantity of a Pd(II) salt, a molar equivalent or more on an Ag(I) basis of an Ag(I) salt, and a molar equivalent or more of a base, in 1,1,1,3,3,3-hexafluoroisopropanol solvent, in the presence of an single enantiomer, either (R) or (S), of an acetyl-protected aminoethyl amine (APAA) ligand of formula wherein Ac is acetyl, each R is independently selected methyl or ethyl, or the two R groups together with the nitrogen atom to which they are bonded form a 4- to 6-membered heterocyclyl ring; and wherein R 1 is an unsubstituted or substituted benzyl group, or wherein R 1 is a (C 3 -C 4 )-alkyl group; to stereoselectively provide a β-aryl-cyclopropanecarboxylic acid, wherein the arylated β-carbon atom of the β-aryl-cyclopropanecarboxylic acid product, when no α-substituent is present is of an (R) or (S) single enantiomeric configuration, respectively, and when an α-substituent is present is of an (S) or (R) single enantiomeric configuration, respectively; the aryl group introduced being disposed cis to the carboxylic acid group of the cyclopropanecarboxylic acid. 2. The method of claim 1 wherein the APAA ligand is of formula 3. The method of claim 1 wherein the Pd(II) salt is Pd(OAc) 2 . 4. The method of claim 1 wherein the carbonate base is Na 2 CO 3 , or wherein the Ag(I) salt is Ag 2 CO 3 , or both. 5. The method of claim 1 wherein the Pd(II) salt is present at about 10 mole %, the ligand is present at about 20 mole %, or both. 6. A method of stereoselective arylation of a β-carbon atom of 2-phthalimidoisobutryic acid, comprising contacting the 2-phthalimidoisobutryic acid and an aryl iodide in the presence of a catalytic quantity of a Pd(II) salt, a molar equivalent or more on an Ag(I) basis of an Ag(I) salt, and a molar equivalent or more of a base, in 1,1,1,3,3,3-hexafluoroisopropanol solvent, in the presence of an single enantiomer, either (R) or (S), of an acetyl-protected aminoethyl amine (APAA) ligand of formula wherein Ac is acetyl, each R is independently selected methyl or ethyl, or the two R groups together with the nitrogen atom to which they are bonded form a 4- to 6-membered heterocyclyl ring; and wherein R 1 is an unsubstituted or substituted benzyl group, or wherein R 1 is a (C 3 -C 4 )-alkyl group; to stereoselectively provide a β-aryl-2-phthalimidoisobutryic acid, wherein the β-aryl-2-phthalimidoisobutryic acid product is of an (R) or (S) single enantiomeric configuration, respectively. 7. The method of claim 6 wherein the APAA ligand is of formula 8. The method of claim 6 wherein the Pd(II) salt is Pd(OAc) 2 . 9. The method of claim 6 wherein the carbonate base is Na 2 CO 3 , or wherein the Ag(I) salt is Ag 2 CO 3 , or both. 10. The method of claim 6 wherein the Pd(II) salt is present at about 10 mole %, the ligand is present at about 20 mole %, or both.

Assignees

Inventors

Classifications

  • C07C67/343Primary

    by increase in the number of carbon atoms · CPC title

  • with oxygen atoms in positions 1 and 3, e.g. phthalimide · CPC title

  • C07C51/353Primary

    by isomerisation; by change of size of the carbon skeleton · CPC title

  • the ester moiety containing a substituent or a structure which is considered as characteristic · CPC title

  • Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11021427B2 cover?
The invention includes procedures for stereoselective β-acylation of carboxylic acids having a β-carbon atom. For example, stereoselective acylation procedures include the following reactions: (I)
Who is the assignee on this patent?
Scripps Research Inst
What technology area does this patent fall under?
Primary CPC classification C07C67/343. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).